INO-8875
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INO-8875, covering 2012-04-30 to 2012-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1, Phase 2]